...
hepa-img

Hepion Pharmaceuticals Inc, Common Stock

HEPA

NAQ

$0.55

-$0.04

(-6.78%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.11M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
38.87K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.81
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.48 L
$3.72 H
$0.55

About Hepion Pharmaceuticals Inc, Common Stock

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameHEPASectorS&P500
1-Week Return-4.81%-2.28%-0.57%
1-Month Return-8.6%-3.98%1.2%
3-Month Return-20.27%-9.71%7.56%
6-Month Return-50.42%-3.39%11.44%
1-Year Return-85.18%3.69%28.47%
3-Year Return-97.54%3.78%29.51%
5-Year Return-99.45%39.76%90.64%
10-Year Return-100%106.88%203.73%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue26.74K34.52K86.07K77.46K67.13K[{"date":"2019-12-31","value":31.06,"profit":true},{"date":"2020-12-31","value":40.1,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.99,"profit":true},{"date":"2023-12-31","value":77.99,"profit":true}]
Gross Profit(26.74K)(34.52K)(86.07K)(77.46K)(67.13K)[{"date":"2019-12-31","value":-2673700,"profit":false},{"date":"2020-12-31","value":-3451500,"profit":false},{"date":"2021-12-31","value":-8607300,"profit":false},{"date":"2022-12-31","value":-7746100,"profit":false},{"date":"2023-12-31","value":-6713100,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses7.77M20.15M30.40M43.62M48.45M[{"date":"2019-12-31","value":16.04,"profit":true},{"date":"2020-12-31","value":41.58,"profit":true},{"date":"2021-12-31","value":62.75,"profit":true},{"date":"2022-12-31","value":90.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(7.77M)(20.15M)(30.40M)(45.49M)(48.45M)[{"date":"2019-12-31","value":-777008500,"profit":false},{"date":"2020-12-31","value":-2014607500,"profit":false},{"date":"2021-12-31","value":-3040330900,"profit":false},{"date":"2022-12-31","value":-4548872600,"profit":false},{"date":"2023-12-31","value":-4844795400,"profit":false}]
Total Non-Operating Income/Expense(175.94K)(208.51K)(2.33M)394.66K(896.68K)[{"date":"2019-12-31","value":-44.58,"profit":false},{"date":"2020-12-31","value":-52.83,"profit":false},{"date":"2021-12-31","value":-589.8,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-227.2,"profit":false}]
Pre-Tax Income(7.95M)(20.32M)(32.72M)(45.08M)(49.34M)[{"date":"2019-12-31","value":-794602000,"profit":false},{"date":"2020-12-31","value":-2032335400,"profit":false},{"date":"2021-12-31","value":-3272216800,"profit":false},{"date":"2022-12-31","value":-4508389800,"profit":false},{"date":"2023-12-31","value":-4933506400,"profit":false}]
Income Taxes(908.68K)30.58K8.86K(2.88M)409.02K[{"date":"2019-12-31","value":-222.16,"profit":false},{"date":"2020-12-31","value":7.48,"profit":true},{"date":"2021-12-31","value":2.17,"profit":true},{"date":"2022-12-31","value":-705.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(7.04M)(20.35M)(32.73M)(42.20M)(49.74M)[{"date":"2019-12-31","value":-703733800,"profit":false},{"date":"2020-12-31","value":-2035393800,"profit":false},{"date":"2021-12-31","value":-3273102700,"profit":false},{"date":"2022-12-31","value":-4220004900,"profit":false},{"date":"2023-12-31","value":-4974408600,"profit":false}]
Income From Continuous Operations(6.72M)(20.35M)(32.72M)(42.20M)(44.68M)[{"date":"2019-12-31","value":-671869800,"profit":false},{"date":"2020-12-31","value":-2035393800,"profit":false},{"date":"2021-12-31","value":-3272216800,"profit":false},{"date":"2022-12-31","value":-4220004900,"profit":false},{"date":"2023-12-31","value":-4467788800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.04M)(20.35M)(32.72M)(42.20M)(48.93M)[{"date":"2019-12-31","value":-703733800,"profit":false},{"date":"2020-12-31","value":-2035393800,"profit":false},{"date":"2021-12-31","value":-3272216800,"profit":false},{"date":"2022-12-31","value":-4220004900,"profit":false},{"date":"2023-12-31","value":-4892604200,"profit":false}]
EPS (Diluted)(26.72)(2.09)(2.94)(2.26)(12.32)[{"date":"2019-12-31","value":-2672,"profit":false},{"date":"2020-12-31","value":-209,"profit":false},{"date":"2021-12-31","value":-294,"profit":false},{"date":"2022-12-31","value":-226,"profit":false},{"date":"2023-12-31","value":-1232,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HEPA
Cash Ratio 0.55
Current Ratio 1.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HEPA
ROA (LTM) -92.82%
ROE (LTM) -189.52%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HEPA
Debt Ratio Lower is generally better. Negative is bad. 1.11
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.11

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HEPA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.11
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Hepion Pharmaceuticals Inc share price today?

Hepion Pharmaceuticals Inc (HEPA) share price today is $0.55

Can Indians buy Hepion Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Hepion Pharmaceuticals Inc (HEPA) on Vested. To buy Hepion Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HEPA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Hepion Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Hepion Pharmaceuticals Inc (HEPA) via the Vested app. You can start investing in Hepion Pharmaceuticals Inc (HEPA) with a minimum investment of $1.

How to invest in Hepion Pharmaceuticals Inc shares from India?

You can invest in shares of Hepion Pharmaceuticals Inc (HEPA) via Vested in three simple steps:

  • Click on Sign Up or Invest in HEPA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Hepion Pharmaceuticals Inc shares
What is Hepion Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Hepion Pharmaceuticals Inc (HEPA) is $3.72. The 52-week low price of Hepion Pharmaceuticals Inc (HEPA) is $0.48.

What is Hepion Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Hepion Pharmaceuticals Inc (HEPA) is

What is Hepion Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Hepion Pharmaceuticals Inc (HEPA) is 2.11

What is Hepion Pharmaceuticals Inc dividend yield?

The dividend yield of Hepion Pharmaceuticals Inc (HEPA) is 0.00%

What is the Market Cap of Hepion Pharmaceuticals Inc?

The market capitalization of Hepion Pharmaceuticals Inc (HEPA) is $4.11M

What is Hepion Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Hepion Pharmaceuticals Inc is HEPA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top